RESEARCH • DEVELOP • COLLABORATE • COMMERCIALISE Early bird registration until December 17th! In May 2022 the annual ATMP congress ‘Advanced Therapies 2022’ is held
Boots-on-the-ground, that is the at.las credo. As a network we aim to support ATMP developers, both academically and commercially, in bringing their product to the
Join this year’s digital conference informing you of the latest technological innovations in cancer research and treatment. Listen to keynote speakers providing accessible insights and
From November 15 – 19 Termis is organizing the 6th World Congress of the Tissue Engineering and Regenerative Medicine Society. Join this digital conference on
Fat-Stem is the first company in Europe to use adipose-derived mesenchymal stem cells for therapeutic use in animals. We spoke with Guy Wouters, founder and
As with other drug molecules, ATMP’s have to comply to the Good Manufacturing Practice (GMP) guidelines, which require the meticulous assessment of both quality and
We created the at.las academy. This online ATMP platform is home to all at.las content- such as webinar recordings, testimonials from colleague developers or point
About 2 years ago a milestone was set in the Belgian Advanced Therapy Medicinal Products (“ATMP”) legislation. The publication took place on October 30th 2018,
Within the CCRG, the University of Antwerp and the UZA collaborate on the development of immunotherapies. These are treatments that wake up the immune system